What is Noveltreat 0.5 mg Pre-filled Pen

Noveltreat 0.5 mg Pre-filled Pen is a subcutaneous injectable treatment containing FDA-approved Semaglutide base (0.5 mg/0.5 ml) as its active ingredient. Semaglutide is a Glucagon-like Peptide-1 (GLP-1) receptor agonist developed to improve glycemic control in adults to help with weight reduction in people who are obese or overweight.

Sun Pharmaceutical Industries Ltd manufactures Noveltreat 0.5 mg Pen in GMP-compliant facilities. To maintain the integrity of this medication, it should be stored in a refrigerator at 2°C-8°C, but not frozen.

As a GLP-1 receptor agonist, Semaglutide binds to and activates GLP-1 receptors in the pancreas and brain. This action triggers glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and promotes a sustained feeling of fullness.

The 0.5 mg dose is the first therapeutic maintenance dose, typically prescribed after patients have completed the four-week initiation period on 0.25 mg. It is used in the long-term management of weight in overweight individuals with conditions such as cardiovascular disease or Type 2 Diabetes.

The pre-filled pen is designed for once-weekly self-injection under the skin of the thigh, abdomen, or upper arm. It can be taken at any time of the day, regardless of meals. Injection sites should be rotated weekly to reduce the likelihood of skin reactions at the same location.

When using Semaglutide, gastrointestinal effects such as nausea and diarrhea can occur. These side effects are typically mild. However, seek immediate medical attention if persistent symptoms like severe abdominal pain develop, which could be a sign of Pancreatitis.

What are the benefits of taking Noveltreat 0.5 mg Pre-filled Pen

Noveltreat 0.5 mg Pre-filled Pen provides targeted metabolic benefits for adults managing Type 2 Diabetes or weight-related health conditions. Some of its benefits include:

• Improved glycemic control: Semaglutide enhances the body's natural insulin response to elevated blood glucose, helping keep hemoglobin A1C (HbA1c) levels within a healthy range.
• Clinically meaningful weight loss: It reduces appetite and caloric intake through appetite-suppressing mechanisms, supporting sustainable weight reduction when combined with lifestyle changes.
• Heart health support: Noveltreat 0.5 mg is beneficial for overweight or obese adults with known cardiovascular disease, helping lower the risk of heart attack, stroke, and cardiovascular death.

How to take Noveltreat 0.5 mg Pre-filled Pen

Noveltreat 0.5 mg Pre-filled Pen is a prescription-only injectable medication. Use it strictly as instructed by your doctor or pharmacist. The general guidelines are as follows:

• Inject once a week, choosing the same day each week for consistency.
• Remove the pen from the refrigerator a few minutes before use to allow it to reach room temperature.
• Administer the injection subcutaneously into the abdomen, thigh, or upper arm, rotating the site with each dose.
• This injection can be taken with or without food, at any time of the day. However, to minimize nausea, small, light meals are ideal.
• Do not administer more than one dose within a week or exceed the recommended dosage.

Strengths and Substitutes

Noveltreat Pre-filled Pen is currently available in a single strength at Cheap Medicine Shop. However, the following effective alternatives are available:

View all substitutes

What are the side effects of Noveltreat 0.5 mg Pre-filled Pen

Noveltreat 0.5 mg Pre-filled Pen can cause side effects in some users, particularly during the early weeks of use. Most side effects are mild and resolve on their own as the body adapts. However, consult a healthcare professional if they persist or worsen:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Injection site reactions
• Fatigue
• Dizziness

Safety Advice

Liver Disease

Noveltreat 0.5 mg should be used cautiously in patients with mild to moderate liver disease. It is not advisable in cases of severe liver impairment. A thorough medical evaluation by a doctor is essential before beginning treatment.

Kidney Impairment

This medication is generally considered suitable for patients with mild to moderate chronic kidney disease. In cases of severe renal impairment, close monitoring is required, as dehydration caused by gastrointestinal side effects can worsen kidney function. Always consult a doctor before using this medicine.

Pregnant and Breastfeeding women

Noveltreat 0.5 mg is not recommended for use during pregnancy. Animal studies have shown adverse effects on fetal development, and the safety in human pregnancies has not been established. Women should discontinue treatment and consult their doctor immediately if they become pregnant during therapy. Breastfeeding while using this medication is also not advised.

Avoid

Do not use this medicine in case of known hypersensitivity to Semaglutide or its inactive ingredients. It is contraindicated in people with a history of Medullary Thyroid Cancer (thyroid gland cancer). Avoid alcohol excess, as it may affect blood sugar levels unpredictably.